Volunteer Assignments and Opportunities: Difference between revisions

No edit summary
Snehal.Patel (talk | contribs)
No edit summary
(15 intermediate revisions by 4 users not shown)
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|Contacted author to clarify 2 references - MS 03/02/21
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
Line 834: Line 834:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 844: Line 844:
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Disease
|Diana Rush
|
|
|
|
|
|PENDING
|
|
|
|YA
|YA
Line 855: Line 855:
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Disease
|Celeste Eno
|
|
|
|
|
|PENDING
|
|
|
|YA
|YA
Line 864: Line 864:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Disease
|Helene Bruyere
|Alaa Koleilat
|
|
|
|
Line 899: Line 908:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
| || ||
|
|
|
|
Line 915: Line 948:
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 924: Line 957:
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Snehal Patel
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 933: Line 966:
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 987: Line 1,020:
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 996: Line 1,029:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Snehal Patel
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,032: Line 1,065:
|
|
|
|
|PENDING
|Complete
| ||SP
|5/26/2021||SP
|
|
|
|
Line 1,045: Line 1,078:
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,054: Line 1,087:
|
|
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,072: Line 1,105:
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
Line 1,081: Line 1,114:
|
|
|-
|-
|    Plasmacytoma||Disease||
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
Line 1,150: Line 1,183:
|
|
|
|
|PENDING
|Complete
| ||SP
|5/28/2021||SP
|
|
|
|
Line 1,182: Line 1,215:
|
|
|-
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|PENDING
|
|
|SP
|SP
|
|
|
|
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|PENDING
|
|
|SP
|SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|Complete
|8/16/2020
|SP
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|Complete
|8/16/2020
|5/26/2021||SP
|SP
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|PENDING
| ||SP
|
|
|
|
Line 2,723: Line 2,756:
|
|
|-
|-
|
|BRCA1
|
|
|
|
Line 2,733: Line 2,766:
|
|
|-
|-
|
|BRCA2
|
|
|
|